FFIV INVESTOR ALERT Robbins Geller Rudman & Dowd LLP Announces that F5, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire December 23, 2025 SAN DIEGO, Dec. 23, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that the F5 class action lawsuit – captioned […]

Data Storage Corporation Extends Expiration Time of Offer to Purchase GlobeNewswire December 23, 2025 MELVILLE, N.Y., Dec. 23, 2025 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“Data Storage” or the “Company”), today announced that it will extend the Expiration Time for its Offer to Purchase. The Offer to Purchase shall be extended from January

Organogenesis Announces Initiation of Biologics License Application for ReNu(R) Initial modules submitted to FDA under rolling review; final modules expected in the first half of 2026 GlobeNewswire December 23, 2025 CANTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization

Avista Posts Updated Corporate Responsibility Report GlobeNewswire December 23, 2025 The latest sustainability information can be found at avistacorp.com. SPOKANE, Wash., Dec. 23, 2025 (GLOBE NEWSWIRE) — Today, Avista (NYSE: AVA) published its latest Corporate Responsibility report and other sustainability information on its corporate website, avistacorp.com. The content reports on Avista's operations and includes commitments

Concentrix Schedules Release of Fourth Quarter and Fiscal Year 2025 Financial Results and Investor Conference Call Webcast GlobeNewswire December 23, 2025 NEWARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, plans to announce its fourth quarter and fiscal year 2025 financial results before market open on

(CNSX:AGN.CN),(OTC US:AGNPF),(Other OTC:AGNPF),(CNSX:AGN),(Boerse Frankfurt – Freiverkehr:AGW0.F), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2025 (GLOBE NEWSWIRE) — Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces an increase to its non-brokered private placement financing,

(NASDAQ:PHUN), Seasoned Finance Executive and Strategic Technology Advisor toGuide Board Strategy Technology and Customer Initiatives AUSTIN, Texas, Dec. 23, 2025 (GLOBE NEWSWIRE) — Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), the enterprise cloud platform for mobile that provides products, solutions, data, and services for brands to engage, manage and monetize global audiences, today announced

(NASDAQ:VOR), BOSTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) — Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the appointment of Andrew Levin, M.D., Ph.D., Partner at RA Capital Management, and Wouter Joustra, General Partner at Forbion, to its Board of Directors. Their appointments follow

(NYSE:DY), WEST PALM BEACH, Fla., Dec. 23, 2025 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY), a leading provider of specialty contracting services to the telecommunications and digital infrastructure industries throughout the United States, today announced that it has completed its previously announced acquisition of Power Solutions, LLC (“Power Solutions”), one of the Mid-Atlantic's largest

Vor Bio Appoints RA Capital's Andrew Levin, M.D., Ph.D., and Forbion's Wouter Joustra to Board of Directors GlobeNewswire December 23, 2025 BOSTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) — Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the appointment of Andrew Levin, M.D., Ph.D.,